Cited by 82Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsDendrimers and Hyperbranched Polymers

Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment

Zhang, Zhen-Tao, Huang-Fu, Ming-Yi, Xu, Wen-Hong, Han, Min·2019·European Journal of Pharmaceutics and Biopharmaceutics

Abstract

The tumor microenvironment is the cellular environment that is also described as the "soil" for supporting tumor growth, proliferation, invasion and metastasis, as well as protecting tumor cells from immunological recognition. Notably, tumor cells can grow much faster than other normal organs and invade surrounding tissues more easily, which results in abnormal expression of enzymes in the tumor microenvironment, including matrix metalloproteinases, cathepsins, phospholipases, oxidoreductases, etc. In opposite, due to the high selectivity and catalytic activity, these enzymes can promote nanoparticles to recognize tumor tissues more accurately, and the more accumulation of drugs at primal tumor sites will enhance therapeutic efficacy with lower systemic toxicity. Therefore, one promising antitumor strategy is to design stimulus-responsive nanoscale delivery systems triggered by the enzymes with the support of various nanocarriers, such as liposomes, micelles and inorganic nanoparticles, etc. In this review, numerous facts were cited to summarize and discuss the typical types of enzyme-stimulus responsive nanoscale delivery systems. More importantly, we also focused on their recent advancements in antitumor therapy, and offered the direction for further studies.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2019.02.009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The tumor microenvironment exhibits aberrant expression of enzymes such as matrix metalloproteinases, cathepsins, phospholipases, and oxidoreductases because tumor cells grow more quickly than other normal organs and require more enzymes for functional support.

    “The tumor microenvironment exhibits aberrant expression of enzymes such as matrix metalloproteinases, cathepsins, phospholipases, and oxidoreductases because tumor cells grow more quickly than other normal organs and require more enzymes for functional support.142”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [142]

  • The binding of uPA and its receptor (uPAR) helps activate the serine protease plasminogen to become plasmin, starting a series of proteolytic cascade reactions to break down the extracellular matrix's components and encourage tumor invasion and metastasis.

    “The binding of uPA and its receptor (uPAR) will help activate the serine protease plasminogen to become plasmin. Afterwards, start a series of proteolytic cascade reactions to break down the extracellular matrix’s components and encourage tumor invasion and metastasis.142,151”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [142]

The citation lists haven’t been fetched yet

References 111 · Cited by 82

Authors
Zhang, Z.-T., Huang-Fu, M.-Y., Xu, W.-H., & Han, M.
Affiliations
Zhejiang University (CN)
Corresponding author
Han, Min
Venue
European Journal of Pharmaceutics and Biopharmaceutics
Publisher
Elsevier BV
Published
2019-04
Volume
137
Pages
122-130
ISSN
0939-6411 (ISSN-L)
OpenAlex
W2912934007
Cited by
82
References
111
Citations by year
2026: 11 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 16 · 2021: 7 · 2020: 9 · 2019: 5
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Basic Research Program of China (2014CB931901)
  • National Natural Science Foundation of China (81673022, 81373346)
  • Zhejiang Provincial Natural Science Foundation of China (LY17H160013, LY15H300001)
  • Fundamental Research Funds for the Central Universities (2017XZZX011-04)
  • Zhejiang Medical and Health Science and Technology Plan Project (2016KYB109)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
enzyme-responsive drug delivery, tumor microenvironment, matrix metalloproteinases, cathepsins, liposomes, micelles, inorganic nanoparticles, targeted drug delivery, cancer therapy, enzyme-responsive drug release
MeSH terms
Animals, Antineoplastic Agents, Enzymes, Humans, Liposomes, Micelles, Neoplasms, Drug Delivery Systems, Nanoparticles, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review